PHAGE 500 TAB is a high-quality oral antidiabetic formulation containing Metformin Hydrochloride 500 mg, specifically designed to aid in the management of Type 2 Diabetes Mellitus. As a first-line therapy recommended by global health authorities, Metformin is recognized for its efficacy, safety profile, and long-standing use in clinical practice for blood glucose regulation.

The active ingredient in PHAGE 500 TAB, Metformin, works by decreasing hepatic glucose production, reducing intestinal absorption of glucose, and improving insulin sensitivity. This multi-pronged mechanism of action helps in maintaining optimal blood sugar levels and minimizing the risk of hyperglycemia without causing significant weight gain or hypoglycemia when used alone.

PHAGE 500 TAB is indicated as monotherapy in newly diagnosed Type 2 diabetic patients and is also frequently used in combination with other oral antidiabetics or insulin in cases requiring enhanced glycemic control. It is particularly effective in overweight and obese individuals due to its potential to support modest weight reduction and its neutral effect on cholesterol levels.

Manufactured by Bluepill Express at WHO-GMP and ISO-certified facilities, PHAGE 500 TAB is formulated using top-grade APIs and pharmaceutical excipients to ensure consistent potency, bioavailability, and stability. The product undergoes rigorous quality checks at every stage of production, from raw material sourcing to final packaging, meeting global regulatory standards for efficacy and patient safety.

PHAGE 500 TAB is available in various packaging options including blister packs, alu-alu strips, and bottles, and can be customized to meet the regulatory and branding requirements of different international markets. Bluepill Express provides full technical and regulatory support, including COA, stability data, master batch records, and dossiers as per client demand for product registration in global regions.

This formulation is also available in extended-release and combination variants to offer dosing flexibility and enhance patient compliance. PHAGE 500 TAB can be integrated into institutional supply chains, hospital purchases, or marketed under private-label branding through Bluepill Express’s end-to-end third-party manufacturing services.

Due to its proven track record in managing diabetes, Metformin as a core ingredient in PHAGE 500 TAB has also been explored for its role in reducing cardiovascular risk and in conditions like Polycystic Ovary Syndrome (PCOS), further expanding its therapeutic utility.

While PHAGE 500 TAB is generally well tolerated, common gastrointestinal side effects such as nausea, diarrhea, and abdominal discomfort may occur during the initial phase of therapy. These effects typically subside with continued use or dose adjustment. Regular monitoring of renal function is advised, especially in elderly patients or those with pre-existing kidney conditions.